Health
Covid-19 to Serve as Platform for South African Vaccine Industry – BloombergQuint
ImmunityBio to Have Covid-19 Vaccine Made in South Africa
(Bloomberg) —
The BioVac Institute, a state-backed South African vaccine company, plans to use a deal it won to manufacture coronavirus shots as a stepping stone toward developing an inoculation export industry in the country.
The contract with U.S.-based ImmunityBio Inc., which is conducting phase 1 vaccine trials in South Africa and the U.S., will allow BioVac to transform itself from a facility that merely packages and labels the shots to one that makes the raw materials, Morena Makhoana, BioVacs…
-
Business22 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend
-
Business24 hours agoWhy this investing expert is calling time on NAB shares
-
General21 hours agoFederal government funding extends cohealth GP services until July 2026
-
Noosa News19 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region